Which of the following antiparkinsonism drugs is an anticholinergic agent?

Questions 52

ATI RN

ATI RN Test Bank

Pharmacology Cardiovascular Drugs Quiz Questions

Question 1 of 5

Which of the following antiparkinsonism drugs is an anticholinergic agent?

Correct Answer: C

Rationale: In this question, the correct answer is C) Trihexyphenidyl. Trihexyphenidyl is an anticholinergic agent commonly used in the treatment of Parkinson's disease to help control tremors and muscle stiffness. Amantadine (A) is not an anticholinergic agent; it works by increasing the release of dopamine in the brain. Selegiline (B) is a monoamine oxidase inhibitor and does not exhibit anticholinergic effects. Bromocriptine (D) is a dopamine agonist used to treat Parkinson's disease by acting on dopamine receptors, but it is not an anticholinergic drug. Understanding the specific mechanisms of action of different antiparkinsonism drugs is crucial for healthcare professionals to make informed decisions when treating patients with Parkinson's disease. Knowing the distinctions between these drugs can help in selecting the most appropriate medication based on the patient's symptoms and individual needs.

Question 2 of 5

Indicate the antipsychotic drug having H1-antihistaminic activity:

Correct Answer: D

Rationale: In this question, the correct answer is D) All of the above. Clozapine, Chlorpromazine, and Olanzapine are all antipsychotic drugs that also exhibit H1-antihistaminic activity. Clozapine is known for its strong H1-antihistaminic effects, which can lead to sedation as a side effect. Chlorpromazine, one of the first antipsychotic medications developed, also possesses H1-antihistaminic properties, contributing to its sedative effects. Olanzapine, a newer atypical antipsychotic, has H1-antihistaminic activity as well, which can result in sedation and weight gain in patients. It is important for students to understand these pharmacological properties of antipsychotic drugs as it helps in predicting and managing their side effects. Knowing that these drugs have H1-antihistaminic activity can guide clinicians in selecting the most appropriate medication based on the patient's symptoms and potential adverse effects. This knowledge enhances the student's understanding of pharmacology and its clinical applications.

Question 3 of 5

Which of the following antidepressants is used for treatment of eating disorders,especially buliemia?

Correct Answer: B

Rationale: In the context of pharmacology, understanding the specific uses of different classes of medications is crucial for effective clinical practice. In the case of treating eating disorders, particularly bulimia, the correct answer is B) Fluoxetine. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that has been shown to be effective in treating bulimia nervosa due to its ability to increase serotonin levels in the brain, which can help regulate mood and reduce binge-eating episodes. A) Amitriptyline and C) Imipramine are tricyclic antidepressants that are not typically used as first-line treatments for eating disorders like bulimia. These medications have a different mechanism of action compared to SSRIs and are more commonly prescribed for conditions such as depression and certain types of chronic pain. D) Tranylcypromine is a monoamine oxidase inhibitor (MAOI), which is another class of antidepressants with a different mechanism of action compared to SSRIs. MAOIs are not commonly used as a first-line treatment for bulimia due to their potential for serious side effects and interactions with certain foods and medications. Educationally, this question highlights the importance of understanding the specific indications for different classes of antidepressant medications. It reinforces the need for healthcare providers to have a solid grasp of pharmacology to make informed decisions regarding drug therapy based on a patient's diagnosis and symptoms. This knowledge is essential for providing safe and effective care to individuals with eating disorders and other mental health conditions.

Question 4 of 5

Indicate the mechanism of hypnotic benzodiazepine action:

Correct Answer: D

Rationale: The correct answer is D) All of the above. Benzodiazepines exert their hypnotic effects by potentiating the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) through binding to GABA-A receptors in the central nervous system. By increasing the duration of GABA-gated Cl- channel openings (option A), benzodiazepines enhance the influx of chloride ions, leading to hyperpolarization of the neuron and ultimately promoting sedation and anxiolysis. Option B, directly activating the chloride channels, is incorrect because benzodiazepines do not directly activate these channels but rather modulate their function through allosteric modulation of the GABA-A receptor. Option C, increasing the frequency of Cl- channel opening events, is also incorrect as benzodiazepines primarily act by enhancing the duration, not the frequency, of channel openings. In an educational context, understanding the mechanism of benzodiazepine action is crucial for healthcare professionals prescribing these medications. Knowing how benzodiazepines interact with GABA receptors can help in predicting their clinical effects and potential side effects. Additionally, this knowledge is essential for selecting the most appropriate pharmacological interventions for patients with anxiety or sleep disorders.

Question 5 of 5

Which of the following general anesthetics belongs to inhalants?

Correct Answer: B

Rationale: In the context of pharmacology, understanding the classification and mechanism of action of different general anesthetics is crucial for safe and effective clinical practice. In this question, the correct answer is B) Desflurane, which belongs to the group of inhalant anesthetics. Desflurane is a volatile liquid administered via inhalation, making it suitable for maintenance of anesthesia during surgical procedures. Its rapid onset and offset of action, along with minimal metabolism in the body, contribute to its popularity in clinical practice. Thiopental (option A) is an intravenous barbiturate used for induction of anesthesia but is not an inhalant anesthetic. Ketamine (option C) is a dissociative anesthetic that is usually administered intravenously or intramuscularly, not via inhalation. Propofol (option D) is another intravenous anesthetic agent commonly used for induction and maintenance of anesthesia, not an inhalant. Educationally, understanding the various routes of administration, mechanisms of action, and specific uses of different anesthetic agents is vital for pharmacology students and healthcare professionals. This knowledge ensures the safe and appropriate selection of anesthetics based on the clinical scenario, patient factors, and desired outcomes.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions